Navidea Biopharmaceuticals
Edit

Navidea Biopharmaceuticals

https://www.navidea.com/
Tags:BioTechCareDevelopmentDiagnosticsHealthPersonalProductTechnologyTools
Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) is a leader in precision medicine with immuno-targeted products designed to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. Applying our Manocept™ technology, Navidea seeks to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases, with an initial focus on personalized Rheumatoid Arthritis diagnostics. The company, founded in 1983, maintains headquarters in Dublin, Ohio.
Likes
1938
Location: United States, Ohio, Dublin
Member count: 11-50
Phone: +1 614-793-7500
Total raised: $60M

Investors 2

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
14.05.2015-$60M-massdevice...

Mentions in press and media 12

DateTitleDescriptionCategoryAuthorSource
04.02.2022Navidea Bi...Navidea Biopharmaceuticals Ann...--marketscre...
17.12.2021Navidea Bi...Navidea Biopharmaceuticals Ter...--marketscre...
10.12.2021Navidea Bi...Navidea Biopharmaceuticals Ann...--marketscre...
27.10.2021Navidea Bi...Navidea Biopharmaceuticals Ann...--marketscre...
20.09.2021Navidea Bi...DUBLIN, Ohio - Navidea Biophar...--marketscre...
17.09.2021Navidea Bi...Navidea Biopharmaceuticals Ann...--marketscre...
14.05.2015Navidea la...Navidea (NYSE:NAVB) is getting...-Mark Hollm...massdevice...
14.05.2015Navidea la...Navidea (NYSE:NAVB) is getting...-Mark Hollm...massdevice...
14.05.2015Navidea la...Navidea (NYSE:NAVB) is getting...-Mark Hollm...massdevice...
22.08.2013Navidea’s ...The presence of amyloid plaque...--medcitynew...
Show more